Next 10 |
2024-04-03 17:42:57 ET More on Avinger Avinger, Inc. (AVGR) Q4 2023 Earnings Call Transcript Avinger enters partnership with Zylox-Tonbridge, to get $15 million of equity funding Seeking Alpha’s Quant Rating on Avinger Historical earnings data for Avin...
2024-03-20 17:56:07 ET Avinger, Inc. (AVGR) Q4 2023 Earnings Conference Call March 20, 2024, 04:30 PM ET Company Participants Matt Kreps - Investor Relations Jeff Soinski - Chief Executive Officer Nabeel Subainati - Principal Financial Officer Conference Ca...
2024-03-20 16:10:19 ET More on Avinger Avinger enters partnership with Zylox-Tonbridge, to get $15 million of equity funding Seeking Alpha’s Quant Rating on Avinger Historical earnings data for Avinger Financial information for Avinger Read t...
New Strategic Partnership Provides Funding to Support U.S. Growth Initiatives and Coronary Product Development, Opens New Pathway for Sales in Asia REDWOOD CITY, CA / ACCESSWIRE / March 20, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing...
Weir Group plc ADR (WEGRY) is expected to report for Q4 2023 So-Young International Inc. (SY) is expected to report for quarter end 2023-12-31 Atara Biotherapeutics Inc. (ATRA) is expected to report $-0.61 for Q4 2023 Adyen NV ADR (ADYEY) is expected to report for Q4 2023 Five Bel...
2024-03-19 17:35:34 ET Major earnings expected after the bell on Wednesday include: Micron Technology ( MU ) Chewy ( CHWY ) Five Below ( FIVE ) KB Home ( KBH ) Corporación América Airports S.A. ( CAAP ) Read the full article on See...
2024-03-17 08:20:00 ET Wall Street has reached a notable lull in the pace of quarterly releases. Still, investors are eagerly anticipating important announcements from FedEx ( NYSE: FDX ) and a set of prominent consumer brands, such as Nike ( NYSE: NKE ), Lululemon Athl...
REDWOOD CITY, CA / ACCESSWIRE / March 12, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced that it will release its finan...
2024-03-10 03:55:00 ET Summary Shenzhen EurekaBio closed a $40 million Series B+ funding to support the commercialization of its EuLV™ Lentiviral Vector Production System. Chengdu Maxvax Biotechnology raised $40 million in a Series C financing round to advance its portfolio...
2024-03-08 08:40:50 ET Losers: Amylyx Pharmaceuticals ( AMLX ) -81% as late-stage ALS trial for Relyvrio fails . BigBear.ai Holdings BBAI -20% after Q4 earnings release . AerSale Corp ASLE -20% after Q4 earnings release . OppFi OPFI -17% aft...
News, Short Squeeze, Breakout and More Instantly...
Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected se...
Shares of Micron Technology, Inc. (NASDAQ: MU) rose sharply in today’s pre-market trading as the company reported upbeat results for its sec...
New Strategic Partnership Provides Funding to Support U.S. Growth Initiatives and Coronary Product Development, Opens New Pathway for Sales in Asia REDWOOD CITY, CA / ACCESSWIRE / March 20, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing...